• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮色林对类癌综合征的症状缓解作用。1例病例

[Symptomatic relief of carcinoid syndrome by ketanserin. A case].

作者信息

Luzzatto G, Pozza M, Cella G

机构信息

Hôpital général de Padoue, Italie.

出版信息

Presse Med. 1995 May 27;24(19):897-9.

PMID:7638130
Abstract

The carcinoid syndrome is a rare clinical entity mainly characterized by flushing and diarrhoea. It is due to different biological mediators produced by tumours that arise from enterochromaffin cells. Such tumours are typically located in the ileum, have a long course and become symptomatic only in the presence of overt liver metastases. Among the involved mediators, the role of serotonin (5-hydroxytryptamine, 5-HT) has been ascertained in the pathogenesis of diarrhoea, while it remains controversial in that of flushing. Ketanserin is a 5HT-2 antagonist with no mixed receptor agonist-antagonist activity. We report the case of a severely distressing carcinoid syndrome fully dominated by ketanserin. The patient was a 75-year-old man, who came to our attention because of marked weight loss, impossibility to feed and almost continuous diarrhoea due to liver colonization of a mid ileum carcinoid tumour, previously resected at the age of 65. Sustained facial and trunk flushing also presented several times daily. Ketanserin, 20 mg twice a day orally, was administered and then increased up to 40 mg daily with no side effects and progressive complete control of both diarrhoea and flushing. It is suggested that ketanserin, due to its availability and tolerability, should first be considered for palliative relief of carcinoid syndrome. The literature on this subject is extensively reviewed.

摘要

类癌综合征是一种罕见的临床病症,主要特征为潮红和腹泻。它是由肠嗜铬细胞产生的不同生物介质所致。此类肿瘤通常位于回肠,病程较长,仅在出现明显肝转移时才会出现症状。在涉及的介质中,血清素(5-羟色胺,5-HT)在腹泻的发病机制中的作用已得到证实,而在潮红的发病机制中仍存在争议。酮色林是一种5HT-2拮抗剂,无混合受体激动剂-拮抗剂活性。我们报告了一例严重困扰的类癌综合征完全由酮色林控制的病例。患者为一名75岁男性,因显著体重减轻、无法进食以及因回肠中段类癌肿瘤肝转移导致的几乎持续腹泻前来就诊,该肿瘤此前在65岁时已切除。面部和躯干持续潮红每天也会出现数次。口服给予酮色林,每日2次,每次20mg,然后增至每日40mg,无副作用,腹泻和潮红逐渐完全得到控制。建议由于酮色林的可用性和耐受性,应首先考虑将其用于类癌综合征的姑息性缓解。本文对该主题的文献进行了广泛综述。

相似文献

1
[Symptomatic relief of carcinoid syndrome by ketanserin. A case].酮色林对类癌综合征的症状缓解作用。1例病例
Presse Med. 1995 May 27;24(19):897-9.
2
Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.类癌综合征与血清素:酮色林的治疗作用
Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:53-8. doi: 10.1007/BF00053427.
3
Ketanserin, a 5-HT antagonist, in symptomatic treatment of carcinoid syndrome.
Ir J Med Sci. 1986 Dec;155(12):436. doi: 10.1007/BF02940548.
4
The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.五肽胃泌素试验在类癌综合征诊断中的应用。酮色林对胃肠道症状的阻断作用。
Ann Surg. 1985 Jan;201(1):81-6.
5
Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial.酮色林与安慰剂治疗类癌综合征的临床对照试验
Scand J Gastroenterol. 1986 Sep;21(7):816-8. doi: 10.3109/00365528609011123.
6
Carcinoid syndrome: comparison of pretreatment regimes in the same patient.类癌综合征:同一患者不同预处理方案的比较
Ann R Coll Surg Engl. 1987 Jan;69(1):16-7.
7
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.使用兰瑞肽Autogel/长效注射剂治疗类癌综合征的患者报告结局:一项国际观察性研究。
Dig Liver Dis. 2016 May;48(5):552-558. doi: 10.1016/j.dld.2015.12.013. Epub 2016 Jan 15.
8
[Symptomatic treatment of the malignant carcinoid syndrome with octreotide].用奥曲肽对恶性类癌综合征进行对症治疗
S Afr Med J. 1989 Jan 7;75(1):30-1.
9
Carcinoid syndrome. Medical management.类癌综合征。药物治疗。
Br J Hosp Med. 1986 Mar;35(3):146-8, 150, 152.
10
[Treatment of carcinoid syndrome with a somatostatin analogue].[用生长抑素类似物治疗类癌综合征]
Orv Hetil. 1992 Mar 22;133(12):731-4.